Decision to anticoagulate is based on length of AF episodes and stroke risk Device detected AF is assoc w lower stroke risk than clinical AF Confirm duration and nature of longest device detected episode Assess stroke risk e g CHA2DS2 VASc

By rray, 26 January, 2024
Exclude Patient Type Detail Header
No
Detail Type
Text
Detail Text
If AF lasts 24h w CHA2DS2 VASc 2 in men 3 in women reasonable to anticoagulate w shared decision making and based on individual pt risk
If AF lasts 5min to 24h w CHA2DS2 VASc 3 reasonable to anticoagulate w shared decision making and based on individual pt risk
If AF episode lasts
Patient Type Detail Header (Long)
Decision to anticoagulate is based on length of AF episodes and stroke risk. Device-detected AF is assoc. w/ lower stroke risk than clinical AF. Confirm duration and nature of longest device-detected episode. Assess stroke risk (e.g., <a href=https://online.epocrates.com/contextuallink/medCalc/AtrialFibCHADSVASc.htm?activeMedCalcName=CHADS-VASc+Score+for+Stroke+Risk+in+Arial+Fibrillation+%28CHA%5B2%5DS%5B2%5D-VASc%29><u>CHA<sub>2</sub>DS<sub>2</sub>-VASc</u></a>).